For the quarter ending 2025-09-30, SGHT made $19,906,000 in revenue. -$8,169,000 in net income. Net profit margin of -41.04%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 19,906,000 | 19,564,000 | 17,508,000 | 19,903,000 |
| Cost of goods sold | 2,709,000 | 2,977,000 | 2,414,000 | 2,777,000 |
| Gross profit | 17,197,000 | 16,587,000 | 15,094,000 | 17,126,000 |
| Research and development | 3,352,000 | 4,387,000 | 4,430,000 | 4,415,000 |
| Selling, general and administrative | 21,750,000 | 23,867,000 | 24,523,000 | 25,812,000 |
| Total operating expenses | 25,102,000 | 28,254,000 | 28,953,000 | 30,227,000 |
| Loss from operations | -7,905,000 | -11,667,000 | -13,859,000 | -13,101,000 |
| Investment income | 965,000 | 1,026,000 | 1,148,000 | 1,487,666.667 |
| Interest expense | 1,306,000 | 1,284,000 | 1,263,000 | 1,170,333.333 |
| Loss on debt extinguishment | 0 | 0 | - | -490,500 |
| Other (expense) income, net | -2,000 | 24,000 | -139,000 | -19,333.333 |
| Loss before income taxes | -8,248,000 | -11,901,000 | -14,113,000 | -13,457,000 |
| Provision for income taxes | -79,000 | 40,000 | 41,000 | 23,333.333 |
| Net loss and comprehensive loss | -8,169,000 | -11,941,000 | -14,154,000 | -13,480,333.333 |
| Net loss per share attributable to common stockholders-basic | -0.16 | -0.23 | -0.28 | -0.27 |
| Net loss per share attributable to common stockholders-diluted | -0.16 | -0.23 | -0.28 | -0.27 |
| Weighted-average shares of common stock outstanding-basic | 52,377,805 | 51,821,773 | 51,290,665 | -68,833 |
| Weighted-average shares of common stock outstanding-diluted | 52,377,805 | 51,821,773 | 51,290,665 | -68,833 |
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)